China's pharma has a 'monkey problem' as tough as 'negotiating with Nvidia'
Why This Matters
Key context: China's lab monkey prices have doubled in a year, with a state lab paying 178,000 yuan ($26,294) each for cynomolgus macaques in June. Biotech executives say securing research primates now feels like negotiating with Nvidia for chips. The monkey shortage is delaying preclinical toxicology studies by four to ten months, threatening China's speed advantage in drug development. Zheshang Securities projects an annual gap of 15,000 to 20,000 monkeys through 2028, with Cambodia imports expected to help. This development from timesofindia.indiatimes.com highlights ongoing changes in the sector.
China's lab monkey prices have doubled in a year, with a state lab paying 178,000 yuan ($26,294) each for cynomolgus macaques in June. Biotech executives say securing research primates now feels like negotiating with Nvidia for chips. The monkey shortage is delaying preclinical toxicology studies by four to ten months, threatening China's speed advantage in drug development. Zheshang Securities projects an annual gap of 15,000 to 20,000 monkeys through 2028, with Cambodia imports expected to help.
Curation & Context
This page summarizes a public news report from timesofindia.indiatimes.com. Global News Hub provides the "Why This Matters" takeaway using editorial insights and AI curation to give readers rapid, high-value context before they click through to read the full article.